Skip to content

Parliamentary Launch of Rare Kidney Diseases Report at House of Commons Roundtable

20 November 2025

This week, we hosted the parliamentary launch of our new report on rare kidney diseases at a high-profile roundtable event in the House of Commons. 

A group of people sitting in a semi-circle around a table
House of Commons Roundtable

The event was hosted by Stuart Andrew MP, Shadow Secretary of State for Health and Social Care, and brought together key voices from patient and clinical communities, government, and industry.

We were honoured to welcome Health Minister Dr Zubir Ahmed MP, Dame June Raine, George Agathangelou (ZS Associates), Professor Louise Oni, and kidney patients Kathryn and 15-year-old Morven, who shared their powerful experiences.

The roundtable highlighted the urgent need for action to support the estimated 160,000 people in the UK living with a rare kidney disease. Discussions focused on building consensus for:

  • Earlier diagnosis
  • Improved access to treatments
  • Greater access to clinical trials for children

 

Alison Railton, director of policy and public affairs, said: “It was heartening to see such shared commitment and passion to make a real difference for patients and families affected by rare kidney diseases.

"We will now build on this momentum to make the case to government for meaningful change.” 

Young adult sitting on panel alongside two women and one man. The young adult is speaking into a microphone.
Morven Hutchison speaking at House of Commons Roundtable
rare-diseases-report-booklet

Collectively common: the devastating impact of rare kidney diseases in the UK

Our independently produced report reveals the impact of rare kidney diseases.

The report shows that people with rare kidney diseases face significant diagnosis delays, inconsistent care and long waits for new treatments, with children in particular left at greater risk of medical, educational, and economic disruption.

Read our latest news

Why not make a donation now?

Every £ counts towards transforming treatments for people living with kidney disease.

Scroll To Top